A Research Study for Patients With Overactive Bladder

Study Identifier
191622-077
CT.gov Identifier
NCT00168454
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Bladder Disorder - Overactive Bladder
    • Study Drug
  • botulinum toxin Type A
  • Placebo
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 85 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Must be between 18-85 years old * Must have been diagnosed by his/her doctor with overactive bladder at least 6 months ago * Must weigh at least 50 kg (110 lbs) * Must be willing and able to record information regarding bladder function into a diary (provided) * Must be willing and able to complete the entire course of the study
    Exclusion Criteria:
    * Cannot currently be catheterizing as a way to control incontinence * Must not have used botulinum toxin type A or any other botulinum toxin previously for any condition

    Protocol Summary

    The purpose of this study is to investigate whether injections of botulinum toxin Type A into the bladder are safe and effective in treating overactive bladder.

    Study Locations

    Location
    Status
    Location
    Pittsburgh, Pennsylvania, United States
    Status
    Not applicable
    Location
    Ghent, Belgium
    Status
    Not applicable
    Location
    Victoria, British Columbia, Canada
    Status
    Not applicable
    Location
    Berlin, Germany
    Status
    Not applicable
    Location
    Warsaw, Poland
    Status
    Not applicable
    Location
    Sheffield, United Kingdom
    Status
    Not applicable